Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370277 · ClinicalTrials.gov registry record
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 36
- Enrollment target
NCT02370277 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 36 participants.
The verdict
NCT02370277 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
This pilot research trial studies the effects of chemotherapy on intestinal bacteria/organisms (microbiota) in patients newly diagnosed with breast cancer. Change in intestinal microbiota may be associated with weight gain in patients treated with chemotherapy. Weight gain has been also associated with cancer recurrence. Examining the types and quantity of bacterial composition in the stool of breast cancer patients treated with chemotherapy may help determine whether body weight and composition are associated with changes in the intestinal microbiota and allow doctors to plan better treatment to prevent weight gain and possibly disease recurrence.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-12-16 |
| Est. Completion | 2018-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370277
The ClinicalTrials.gov registry entry for NCT02370277 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02370277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370277 about?
NCT02370277 is a clinical study titled "Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer". This pilot research trial studies the effects of chemotherapy on intestinal bacteria/organisms (microbiota) in patients newly diagnosed with breast cancer. Change in intestinal microbiota may be associated with weight gain in patients treated with chemotherapy. Weight gain has been also associated w...
What is the current status of trial NCT02370277?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2014-12-16. Estimated completion is 2018-08-22.
What interventions are being tested in trial NCT02370277?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02370277?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.